JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ehlert, F. J.
Right arrow Articles by Bailon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ehlert, F. J.
Right arrow Articles by Bailon, R.

Vol. 289, Issue 2, 981-992, May 1999

A Simple Method for Estimation of Agonist Activity at Receptor Subtypes: Comparison of Native and Cloned M3 Muscarinic Receptors in Guinea Pig Ileum and Transfected Cells1

Frederick J. Ehlert, Michael T. Griffin, Gregory W. Sawyer and Regina Bailon

Department of Pharmacology, College of Medicine, University of California-Irvine, Irvine, California (F.J.E., R.B.); and Department of Chemistry, Chapman University, Orange, California (M.T.G.)

We describe a simple method for calculating the pharmacological activity of an agonist (A) relative to a standard agonist (S) using only the concentration-response curves of the two agonists. In most situations, we show that the product of the ratios of maximal responses (Emax - A/Emax - S) and potencies (EC50 - S/EC50 - A) is equivalent to the product of the affinity and intrinsic efficacy of A expressed relative to that of S. We refer to this term as the IRA value of A. In a cooperative system where the concentration-response curve of the standard agonist is steep and that of the test agonist is flatter with a lower maximal response, the simple calculation of IRA described above underestimates agonist activity; however, we also describe a means of correcting the IRA in this situation. We have validated our analysis with modeling techniques and have shown experimentally that the IRA values of muscarinic agonists for stimulating contractions in the guinea pig ileum (M3 response) are in excellent agreement with those measured in the phosphoinositide assay on Chinese hamster ovary cells expressing the M3 muscarinic receptor.

0022-3565/99/2892-0981$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
K. W. Figueroa, M. T. Griffin, and F. J. Ehlert
Selectivity of Agonists for the Active State of M1 to M4 Muscarinic Receptor Subtypes
J. Pharmacol. Exp. Ther., January 1, 2009; 328(1): 331 - 342.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
T. Sakamoto, T. Unno, T. Kitazawa, T. Taneike, M. Yamada, J. Wess, M. Nishimura, and S. Komori
Three distinct muscarinic signalling pathways for cationic channel activation in mouse gut smooth muscle cells
J. Physiol., July 1, 2007; 582(1): 41 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
K. A.E. van't Slot, A. Gierlich, and W. Knogge
A Single Binding Site Mediates Resistance- and Disease-Associated Activities of the Effector Protein NIP1 from the Barley Pathogen Rhynchosporium secalis
Plant Physiology, July 1, 2007; 144(3): 1654 - 1666.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. T. Griffin, K. W. Figueroa, S. Liller, and F. J. Ehlert
Estimation of Agonist Activity at G Protein-Coupled Receptors: Analysis of M2 Muscarinic Receptor Signaling through Gi/o,Gs, and G15
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1193 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
F. J. Ehlert
Analysis of Allosterism in Functional Assays
J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 740 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. D. C. Ward, C. A. M. Curtis, and E. C. Hulme
Alanine-Scanning Mutagenesis of Transmembrane Domain 6 of the M1 Muscarinic Acetylcholine Receptor Suggests that Tyr381 Plays Key Roles in Receptor Function
Mol. Pharmacol., November 1, 1999; 56(5): 1031 - 1041.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.